In addition, in primary GC, GPX4-Mpr1/Pad1 N-terminal domain-containing protein (MPND) fusion gene can facilitate tumor growth and progression,13 which suggests that GPX4 may be a potential molecular marker for early diagnosis and prognosis of GC. This evidence concerns the gene IGF2R and gastric cancer.